NPCE compared with AXGN: revenue, margins and what each company keeps, and the suppliers and customers both name

NPCENeuroPace Inc

Mkt capRevenueRevenue

AXGNAxogen, Inc.

Mkt capRevenueRevenue

Compare

NPCENeuroPace Inc

AXGNAxogen, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

NPCE

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±33.3%▼−3.26%×0.10

May 13 '26±15.3%▲+0.06%×0.01

Q1 FY26±32.3%▲+0.87%×0.03

Q3 FY25±55.7%▲+38.09%×0.68

AXGN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±19.5%▲+31.47%×1.62

Q2 FY26±16.1%▲+0.53%×0.03

= impliedNPCE realized, solidAXGN realized, hatchedOne scale, both sides: full bar = 56%× = |realized| ÷ impliedSource: market data

Q1 FY26

±15.4%

▲+6.60%

×0.43

Feb 24 '26±13.3%▼−8.14%×0.61

NPCENeuroPace Inc

12.28▼−5.61%· post 12.28

Mkt cap$422.2MRevenue$23MQ2 FY26Revenue$96MFY25

AXGNAxogen, Inc.

49.37▼−0.52%· post 49.37

ClosedOct 30 '26

Mkt cap$2.9BRevenue$76MQ3 FY26Revenue$225MFY25

Compare

ClosedOct 30 '26

NPCENeuroPace Inc

AXGNAxogen, Inc.

12.28▼−5.61%post 12.28

Price

49.37▼−0.52%post 49.37

$422.2M

Mkt cap

$2.9B

Q2 FY26$23M

Revenue

$76MQ3 FY26

FY25$96M

Revenue

$225MFY25

NPCE12.28▼−5.61%vsAXGN49.37▼−0.52%ClosedOct 30 '26